These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23074987)

  • 21. A Novel Series of N-aryltriazole and N-acridinyltriazole Hybrids as Potential Anticancer Agents.
    Rono CK; Darkwa J; Meyer D; Makhubela BCE
    Curr Org Synth; 2019; 16(6):900-912. PubMed ID: 31984911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A monofunctional platinum(II)-based anticancer agent from a salicylanilide derivative: Synthesis, antiproliferative activity, and transcription inhibition.
    Wang B; Wang Z; Ai F; Tang WK; Zhu G
    J Inorg Biochem; 2015 Jan; 142():118-25. PubMed ID: 25450026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigating the cellular fate of a DNA-targeted platinum-based anticancer agent by orthogonal double-click chemistry.
    Qiao X; Ding S; Liu F; Kucera GL; Bierbach U
    J Biol Inorg Chem; 2014 Mar; 19(3):415-26. PubMed ID: 24407462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design of a platinum-acridine-endoxifen conjugate targeted at hormone-dependent breast cancer.
    Ding S; Qiao X; Kucera GL; Bierbach U
    Chem Commun (Camb); 2013 Mar; 49(24):2415-7. PubMed ID: 23416453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A membrane transporter determines the spectrum of activity of a potent platinum-acridine hybrid anticancer agent.
    Yao X; Watkins NH; Brown-Harding H; Bierbach U
    Sci Rep; 2020 Sep; 10(1):15201. PubMed ID: 32939009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gold(I) analogues of a platinum-acridine antitumor agent are only moderately cytotoxic but show potent activity against Mycobacterium tuberculosis.
    Eiter LC; Hall NW; Day CS; Saluta G; Kucera GL; Bierbach U
    J Med Chem; 2009 Nov; 52(21):6519-22. PubMed ID: 19803526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis and anticancer evaluation of acridine hydroxamic acid derivatives as dual Topo and HDAC inhibitors.
    Chen J; Li D; Li W; Yin J; Zhang Y; Yuan Z; Gao C; Liu F; Jiang Y
    Bioorg Med Chem; 2018 Aug; 26(14):3958-3966. PubMed ID: 29954683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and antiproliferative activity of 9-benzylamino-6-chloro-2-methoxy-acridine derivatives as potent DNA-binding ligands and topoisomerase II inhibitors.
    Zhang W; Zhang B; Zhang W; Yang T; Wang N; Gao C; Tan C; Liu H; Jiang Y
    Eur J Med Chem; 2016 Jun; 116():59-70. PubMed ID: 27060757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tuning the DNA conformational perturbations induced by cytotoxic platinum-acridine bisintercalators: effect of metal cis/trans isomerism and DNA threading groups.
    Choudhury JR; Guddneppanavar R; Saluta G; Kucera GL; Bierbach U
    J Med Chem; 2008 Jun; 51(11):3069-72. PubMed ID: 18457380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA Adduct Detection after Post-Labeling Technique with PCR Amplification (DNA-ADAPT-qPCR) Identifies the Pre-ribosomal RNA Gene as a Direct Target of Platinum-Acridine Anticancer Agents.
    Yao X; Bierbach U
    Chemistry; 2021 Oct; 27(59):14681-14689. PubMed ID: 34375484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New bio-sensitive and biologically active single crystal of pyrimidine scaffold ligand and its gold and platinum complexes: DFT, antimicrobial, antioxidant, DNA interaction, molecular docking with DNA/BSA and anticancer studies.
    Sankarganesh M; Dhaveethu Raja J; Sakthikumar K; Solomon RV; Rajesh J; Athimoolam S; Vijayakumar V
    Bioorg Chem; 2018 Dec; 81():144-156. PubMed ID: 30121002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, DNA-binding and antiproliferative properties of acridine and 5-methylacridine derivatives.
    Ferreira R; Aviñó A; Mazzini S; Eritja R
    Molecules; 2012 Jun; 17(6):7067-82. PubMed ID: 22683895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Second-generation testosterone-platinum(II) hybrids for site-specific treatment of androgen receptor positive prostate cancer: Design, synthesis and antiproliferative activity.
    Ouellette V; Côté MF; Gaudreault RC; Tajmir-Riahi HA; Bérubé G
    Eur J Med Chem; 2019 Oct; 179():660-666. PubMed ID: 31279298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Replacement of a thiourea with an amidine group in a monofunctional platinum-acridine antitumor agent. Effect on DNA interactions, DNA adduct recognition and repair.
    Kostrhunova H; Malina J; Pickard AJ; Stepankova J; Vojtiskova M; Kasparkova J; Muchova T; Rohlfing ML; Bierbach U; Brabec V
    Mol Pharm; 2011 Oct; 8(5):1941-54. PubMed ID: 21806015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of benzimidazole acridine derivatives as potential DNA-binding and apoptosis-inducing agents.
    Gao C; Li B; Zhang B; Sun Q; Li L; Li X; Chen C; Tan C; Liu H; Jiang Y
    Bioorg Med Chem; 2015 Apr; 23(8):1800-7. PubMed ID: 25778766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-activity relationships for substituted bis(acridine-4-carboxamides): a new class of anticancer agents.
    Gamage SA; Spicer JA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
    J Med Chem; 1999 Jul; 42(13):2383-93. PubMed ID: 10395479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors.
    Behbahani FS; Tabeshpour J; Mirzaei S; Golmakaniyoon S; Tayarani-Najaran Z; Ghasemi A; Ghodsi R
    Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800307. PubMed ID: 31012156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, antitumor cytotoxicity, and DNA-binding of novel N-5,2-di(omega-aminoalkyl)-2,6-dihydropyrazolo[3,4,5-kl]acridine-5-carboxamides.
    Antonini I; Polucci P; Magnano A; Martelli S
    J Med Chem; 2001 Sep; 44(20):3329-33. PubMed ID: 11563932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and Biological Evaluation of Acridine/Acridone Analogs as Potential Anticancer Agents.
    Gensicka-Kowalewska M; Cichorek M; Ronowska A; Deptuła M; Klejbor I; Dzierzbicka K
    Med Chem; 2019; 15(7):729-737. PubMed ID: 30324889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of modified acridines: the effect of N- and O- substituent in the nitrogenated ring on antitumor activity.
    Sánchez I; Reches R; Caignard DH; Renard P; Pujol MD
    Eur J Med Chem; 2006 Mar; 41(3):340-52. PubMed ID: 16413635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.